Last signal *sell ~ 9200 based on SMI generated signal coupled with Transform for directional prediction. Expect 7045 area to offer support based on transform exhaustion area. Neutral for now from bearish provided the support level mentioned holds.
Really? As in ......."Is the transform correct"? Watching pan out here. Short may be the move...
Transform indicates basing done. Rolling with this signal. Expecting DXY correlation to ensue. GL> Stop setting ~ 1130.
News Jitters before reading the whole story. My view, not much difference in company ops with the CEO shift.
Regression targets based on 5 and 10 event calcs. Suitor in the wings rumor mill. Very possible targets that taken into consideration. Otherwise, current rate of climb bias toward the 10 event calc. As with any target ticker, considering that being binary in nature, radical price variances could occur. Good Luck ........Happy Holidays.
Volume Oscillator in concert with this latest move. Nice looking expansion bollinger. GL
Possible topping as witnessed by chart details.
1320 best guess based on trendline. Catalyst on technical basis is Transform. Modified RSI coiling.
Long signal generation i/e RSI Modified version to suit commodity.
Using simple Dual Linear regression techniques A bit Leptokurtic with subsequent fade to reality as of late. Following the trend.
Transform logic. Canned Fisher with modifications. Watching for obv to validate. GL.
Transforms work well in my experience with many commodities. Crude, tough to call many times. This works for me as a precursory approach. That said, the OBV increases and washouts act as check to validate further the indications of the transform. Testing phase, albeit, nearly complete. GL>
Double bottom possibility if not for the ACC/DIST dump occuring. MACD was accurate calling this out with the reduction in Y axis top of MACD cycles. Furthermore, RSI confirmed early on the possibility of a decline of this nature. Investments change on the spur of the moment. Presently, I would say the prudent approach would be the sidelines. Once support is...
Interesting and somewhat reliable RSI/OBV/MACD bullish indication as viewed on chart. Synergy with cancer drugs may indeed provide nice profit stream to propel this issue.
$GE OBV indicates hold. Note absence of meaningful selling pressure as view by this indicator. Note the 5 minute and daily interval charts.
Consider this: Several months back, this stock broke out with wholesale backing along with retail investor enthusiasm over several products in the pipeline with promising outlooks. Since then, .........news about ongoing trials with positive results to date. No bad news regarding any of the pipeline. IBB correction along with most of the biotech sector in normal...
Favored power producer over fossil fuel alternatives. Apparently in sold growth phase.